Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

American Healthcare REIT (AHR) Operating Expenses (2016 - 2025)

American Healthcare REIT (AHR) has disclosed Operating Expenses for 10 consecutive years, with $567.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Operating Expenses rose 12.76% year-over-year to $567.6 million, compared with a TTM value of $2.1 billion through Dec 2025, up 8.0%, and an annual FY2025 reading of $2.1 billion, up 8.0% over the prior year.
  • Operating Expenses was $567.6 million for Q4 2025 at American Healthcare REIT, up from $530.5 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.1 billion in Q4 2021 and bottomed at $287.4 million in Q1 2021.
  • Average Operating Expenses over 5 years is $471.0 million, with a median of $453.9 million recorded in 2023.
  • The sharpest move saw Operating Expenses surged 702.28% in 2021, then crashed 61.97% in 2022.
  • Year by year, Operating Expenses stood at $1.1 billion in 2021, then plummeted by 61.97% to $434.9 million in 2022, then increased by 5.06% to $456.9 million in 2023, then rose by 10.17% to $503.4 million in 2024, then increased by 12.76% to $567.6 million in 2025.
  • Business Quant data shows Operating Expenses for AHR at $567.6 million in Q4 2025, $530.5 million in Q3 2025, and $496.1 million in Q2 2025.